Symbiota, a Cambridge, MA-based developer of microbial solutions that naturally promote plant health and improve agricultural production, raised $7.5m in Series A financing.
Flagship Ventures made the investment.
After two years of development in stealth mode, Symbiota is advancing microbial solutions that naturally promote plant health and improve agricultural production by leveraging the beneficial microbes that reside within plants. The company has built a substantial platform and advanced multiple products into greenhouse and field trials in crops including corn, soy, wheat, cotton and vegetables.
Symbiota is led by Co-Founder and President Dr. Geoffrey von Maltzahn, and Co-Founder and Board Member Dr. David Berry.